Please provide your email address to receive an email when new articles are posted on . FRANKFURT, Germany — Corneal cross-linking proved to be an effective alternative treatment for recurrent corneal ...

Keratoconus is a noninflammatory, progressive, bilateral ectatic corneal disease with corneal stromal thinning that results in weakening and surface distortion of the cornea. The onset of this disease ...

Matrix regenerating agents (RGTAs) emerged as promising in vivo wound-healing agents. These agents could prove beneficial for the treatment of dry eye disease-associated corneal micro-erosions; ...

Corneal cross-linking is a treatment for an eye problem called keratoconus. In this condition, the front part of your eye, called the cornea, thins out and gets weaker over time. This makes it bulge ...

This story is part of a series on the current progression in Regenerative Medicine. This piece is part of a series dedicated to the eye and improvements in restoring vision. In 1999, I defined ...

The persistent corneal edema market is experiencing steady growth, driven by rising clinical awareness, improved postoperative monitoring, and growing focus on endothelial dysfunction-related ...

The US Food and Drug Administration (FDA) has cleared GenEditBio Limited’s Investigational New Drug (IND) application to ...